VPHIF Stock Price, Chart, Stats & News

Valeo Pharma Inc.
Save
Valeo Pharma Inc. (VPHIF) does not currently pay a dividend.
9,866
Market cap
–
Current P/E
21.23x
Forward P/E
VPHIF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism.
Similar securities
Based on sector and market capitalization
Report issue





